ImmunologybioRxiv
LRRK2 G2019S promotes the development of colon cancer via modulating intestinal inflammation
Yuhang Wang, Joyce Z. Gao, Taylor Sakaguchi…·Zizhen Kang
This study shows that LRRK2 G2019S promotes colon cancer by enhancing intestinal inflammation and tumor growth in mice.
DOI 10.3390/cells13070565